Menu Back toSession-3-Track-1-The-Future-Of-Medical-Affairs-The-Voice-of-the-Visionary

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

Session 3 Track 1: The Future Of Medical Affairs: The Voice of the Visionary

Session Chair(s)

Anne  Arvizu, PharmD

Anne Arvizu, PharmD

  • Chief Executive Officer and Medical Affairs Advisor
  • RxER Communications Corp, United States
Isabelle C. Widmer, DrMed

Isabelle C. Widmer, DrMed

  • Medical Affairs Consultant
  • elytra GmbH, Switzerland
There are various ideas, assets, and resources to our industry. This panel interview represents a new concept at MASC. Senior executive industry leaders, founders, and way-makers are being brought together to discuss their vision, why they founded their organizations, answer questions, and demonstrate how they continually move forward. We’ll focus our emphasis on niche markets, organizational design, and necessary business acumen in an ever-changing industry environment, to add as much value as possible. For the manager to director level MI observer, awareness of resources can be unclear. Participants will walk away with invaluable insight to think about what’s coming in the future of our industry, and to be able to apply takeaways for any sized company small, mid-sized, and large Pharma/Biotech.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Identify the differences of major organizations and the value they provide and their niche
  • Discuss the vision behind each and how to apply what is needed when they need it to small, mid-sized, and large Pharma/Biotech


Dominick L. Albano


Dominick L. Albano

  • Pfizer, Inc., United States
Patrick  Reilly, MS, MSc


Patrick Reilly, MS, MSc

  • CEO
  • phactMI, United States
William A. Soliman, PhD


William A. Soliman, PhD

  • President
  • ACMA, United States